Mendelian Randomization Uncovers Potential Repurposable Medications for Neuropsychiatric Disorders
MR-based drug repurposing is a promising approach for the treatment of neuropsychiatric disorders. Further validation is necessary to effectively integrate these medications into clinical practice.
Authors
- Shanling Liu (ORCID: https://orcid.org/0000-0001-8788-7991)
- Linbo Gao (ORCID: https://orcid.org/0000-0002-7572-8990)
- Lin Zhang (ORCID: https://orcid.org/0000-0002-1362-3309)
- Qiang Wang (ORCID: https://orcid.org/0000-0001-5095-4062)
- Tingyu Li (ORCID: https://orcid.org/0000-0002-1940-7076)
- Xiao Xiao (ORCID: https://orcid.org/0009-0009-9826-2677)
Institutions
- Sichuan University (CN)
- West China Second University Hospital of Sichuan University (CN)
Publication Details
- Journal
- Current Neuropharmacology
- Published
- 2025-06-13
- DOI
- https://doi.org/10.2174/011570159x368382250527073353
- Primary Topic
- Genomics and Rare Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00